| RS2135689111 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, ATM-related cancer predisposition |
| RS2135690451 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135690630 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135690723 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135691240 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2135691302 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Ataxia-telangiectasia syndrome |
| RS2135691310 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135698596 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135699140 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135699333 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135702107 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2135704274 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135704461 |
ATM
|
Health Risk |
Likely pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2135704536 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135705450 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135706408 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135707160 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2135707267 |
MED17
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly, Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly |
| RS2135707669 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135707883 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135707910 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2135707999 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2135708324 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135708403 |
ATM
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2135709622 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135709779 |
ATM
|
Health Risk |
Likely pathogenic |
Breast cancer, susceptibility to |
| RS2135710049 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135710273 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135711169 |
HOGA1
|
Health Risk |
Pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2135711274 |
HOGA1
|
Health Risk |
Pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2135712224 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2135713786 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2135713875 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2135714806 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2135714832 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2135715560 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2135717849 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2135721049 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135721485 |
HOGA1
|
Health Risk |
Likely pathogenic |
— |
| RS2135721573 |
MED17
|
Health Risk |
Likely pathogenic |
— |
| RS2135721735 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS2135722254 |
HOGA1
|
Health Risk |
Likely pathogenic |
— |
| RS2135722265 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS2135722313 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2135722358 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2135722531 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS2135722575 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS2135723056 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2135723890 |
HOGA1
|
Health Risk |
Likely pathogenic |
— |
| RS2135727106 |
C1S
|
Health Risk |
Pathogenic |
Complement component C1s deficiency, Complement component C1s deficiency |
| RS2135729861 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS2135729949 |
C1S
|
Health Risk |
Pathogenic |
— |
| RS2135732554 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135733332 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2135733393 |
MYO7A
|
Health Risk |
Pathogenic |
Ear malformation, Ear malformation |
| RS2135733425 |
SMARCC2
|
Health Risk |
Pathogenic |
— |
| RS2135733500 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135733729 |
SMARCC2
|
Health Risk |
Likely pathogenic |
SMARCC2-related BAFopathy, SMARCC2-related BAFopathy |
| RS2135734683 |
SMARCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Coffin-Siris syndrome 8, Coffin-Siris syndrome 8 |
| RS2135735043 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135735093 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135735834 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135736277 |
STIM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stormorken syndrome, Combined immunodeficiency due to STIM1 deficiency |
| RS2135736601 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135736648 |
STIM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency due to STIM1 deficiency, Myopathy with tubular aggregates |
| RS2135736779 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135736874 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135737651 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135738057 |
POC1B
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 20, Cone-rod dystrophy 20 |
| RS2135738163 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135738753 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2135739220 |
SHANK2
|
Health Risk |
Pathogenic |
Autism, susceptibility to |
| RS2135739702 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135742927 |
SUFU
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS2135743218 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135743382 |
SUFU
|
Health Risk |
Pathogenic |
Medulloblastoma, Gorlin syndrome |
| RS2135748075 |
MYRF
|
Health Risk |
Likely pathogenic |
Disorder of sexual differentiation, Disorder of sexual differentiation |
| RS2135748375 |
MYRF
|
Health Risk |
Pathogenic |
— |
| RS2135750262 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135750656 |
SMARCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2135751048 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135751909 |
SHANK2
|
Health Risk |
Pathogenic |
Autism, susceptibility to |
| RS2135752319 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135752682 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135753345 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135753552 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135753954 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135753984 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135757801 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2135758861 |
EIF2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS2135759698 |
EIF2B1
|
Health Risk |
Pathogenic |
— |
| RS2135760052 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135760623 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135761807 |
EIF2B1
|
Health Risk |
Pathogenic |
— |
| RS2135762072 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135762079 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2135762104 |
SHANK2
|
Health Risk |
Pathogenic |
— |
| RS2135762199 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135762355 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135762420 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |